Navigation Links
Vermillion Reports Financial Results for the First Quarter 2011
Date:5/10/2011

the Johns Hopkins University School of Medicine to identify biomarkers that improve on the specificity of CA125 for the identification of malignant ovarian tumors.
  • Commenced enrollment of subjects in the PAD intended use study being performed in collaboration with the Colorado Prevention Center. The study remains on track to result in top-line data during the third quarter of 2011.
  • Strengthened our balance sheet by completing an underwritten follow-on public offering of our common stock, resulting in approximately $20.2 million net proceeds to the Company.

  • "We continued to make progress in multiple areas during the first quarter.  We grew OVA1 sales as well as had several presentations highlighting the benefit of OVA1 as an aid for physicians in the assessment of adnexal masses.  On the clinical development front, our PAD and OVA2 programs moved forward and remain on track to generate data later this year.  We also strengthened our balance sheet, which affords us the flexibility to help accelerate our current initiatives as well as opportunistically act on potential new growth drivers," said Gail S. Page, Chair of the Board of Directors and CEO.

    For the second quarter of 2011, we expect 3,200 to 3,500 OVA1 tests to be performed.  This forward guidance takes into consideration numerous factors including the number of days in the quarter, continued limited coverage by the larger payers, and the ability to expand the number of diagnosis codes currently approved by Medicare.

    Total revenues for the first quarter of 2011 were $431,000 compared to $73,000 for the first quarter of 2010.  Revenues for the first quarter of 2011 included $317,000 from product sales of OVA1 and $114,000 of license revenue related to the Company's achievement of certain milestones under the Strategic Alliance Agreement with Quest Diagnostics.  As of March 31, 2011, the Company's cash and short-term investments totaled $40.2
    '/>"/>

    SOURCE Vermillion, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Vermillion Receives Award From the Society of Gynecologic Oncologists
    2. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
    3. Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder
    4. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
    5. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
    6. Vermillion Presents Critical Data From Its OVA1 Clinical Trial
    7. Vermillion Announces the Reappointment of Officers and Confirmation of Director
    8. Vermillion to Present at Lazard Capital Markets Sixth Annual Healthcare Conference
    9. Vermillion Announces $43.05 Million Private Placement of Common Stock
    10. Vermillion Files Plan of Reorganization
    11. Vermillion Files Amended Plan of Reorganization and Exchanges Debt
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/20/2015)... , April 20, 2015  SillaJen, Inc., a ... of oncolytic immunotherapy products for cancer, today announced ... the Annual Meeting of the American Association for ... murine adapted version of its lead product candidate, ... is an oncolytic immunotherapy designed to 1) rapidly ...
    (Date:4/20/2015)... , April 20, 2015 The preclinical contract research ... testing of drugs and safety testing of medical devices, announces ... at this week,s workshop " Drug Transporters in ADME: From ... MD . The title of Dr. Hidalgo,s talk is ... a session entitled "Transporter Tools of the Future." ...
    (Date:4/20/2015)... , April 20, 2015   Gateway ... Research and Training Institute today expanded its Naloxone: ... outpatient locations.  A $50,000 grant from the ... research project possible.  The yearlong ... to patients and their family members upon completion ...
    Breaking Medicine Technology:SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 2SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 3Absorption Systems Chief Scientist Ismael Hidalgo to Present at International Workshop on Drug Transporters 2Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 2Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 3
    ... Calif., Dec. 4 Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) ... Amended Plan of Reorganization and related amended Disclosure Statement with ... , A hearing to consider the adequacy of ... with the hearing on the confirmation of the Plan scheduled ...
    ... , EMERYVILLE, Calif., Dec. 4 ... it will host an investor teleconference and webcast. Principal ... and/or refractory multiple myeloma, as featured at the 51st American ... begin at 9:00 a.m. CT/10:00 a.m. ET on Monday, December ...
    Cached Medicine Technology:Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2
    (Date:4/20/2015)... Bronx, NY (PRWEB) April 20, 2015 The ... are introducing the community to Bella Diosa Laser Med Spa ... invited to a spa party on from 12–7 p.m. on ... The event will include drinks and refreshments. Participants will also ... Attendees will receive a free gift with any purchase, as ...
    (Date:4/20/2015)... is a seemingly idyllic and tranquil island oasis in ... off the southeastern coast of Africa, the tiny nation ... everyone lives together in harmony. , But the shimmering ... drug abuse. In fact, it carries a dubious designation: ... in eastern Africa. , “Many youngsters, they know the ...
    (Date:4/20/2015)... (PRWEB) April 20, 2015 At the ... held the “RockNRolla Movie Awards” EcoLuxe Lounge, with Choices ... Angeles’ leading producer of sustainable product placement in TV ... of socially conscious and ecologically sound goods and services ... star Chase Masterson hosted the Choices Celebrity Interview Lounge, ...
    (Date:4/20/2015)... Connecticut (PRWEB) April 20, 2015 ... Moreen Donahue, DNP, RN, NEA-BC, FAAN who was ... Nursing Education and Research in September 2014, is ... Nursing Officer to lead the development of Western ... this newly created role, Donahue will be responsible ...
    (Date:4/20/2015)... 2015 The normal response from the doctor ... we could do.” Especially if the patient sought medical care ... should be much different. So it’s critical the patient’s loved ... be done?” , Not every emergency room physician or ... can be done.” But, according to Ronald P. Benitez ...
    Breaking Medicine News(10 mins):Health News:Bella Diosa Says Hello to Yonkers Community with Spa Party 2Health News:Voice For Humanity: Choolun Bhojoo leads the fight to rid Mauritius of a drug plague 2Health News:Choices Recovery South Bend Talks About Healthy Decisions with TV's Adrienne Janic 2Health News:Nursing Executive to Develop and Lead Nursing Leadership Program at Western Connecticut Health Network 2Health News:"What More Can Be Done?” – The Critical Question That Can Save a Stroke Victim 2Health News:"What More Can Be Done?” – The Critical Question That Can Save a Stroke Victim 3
    ... ... wellness. Learn how to improve the look and strength of your abdominal muscles and improve ... on this new Web site. , ... June 17, 2010 -- A new Web site has been developed to help anyone get in ...
    ... ... to Bring Fresh, Locally Sourced, All-Natural Snacks and Beverages to Kicks 4 Kids Community ... ... First Soccer and the McHenry Area Soccer Federation have partnered with McHenry’s Healthy U ...
    ... now new areas in which whole body magnetic resonance imaging ... Deutsches rzteblatt International ( Dtsch Arztebl Int 2010; ... of possible uses, together with the limits of this radiation-free ... routine use in hospitals, as the procedure takes less than ...
    ... is a great deal of interest in factors that contribute ... One factor that appears to contribute to the heritable ... codes for the serotonin transporter, also known as the serotonin ... transporter gene appears to increase one,s risk for depression and ...
    ... role of N-terminal pro-B-type natriuretic peptide (NT-proBNP, a protein ... a robust, non-invasive predictor of cardiovascular (CV) risk in ... by the results of a multinational study presented today ... League Against Rheumatism in Rome, Italy. The presence ...
    ... Grant to ... Athletes , ... June 17, 2010 -- Athletes for Hope (AFH), an entrepreneurial non-profit founded by 12 of ... purpose of inspiring all athletes to engage in positive social impact, has been awarded a ...
    Cached Medicine News:Health News:New Web Site Provides Helpful Exercise and Nutrition Tips 2Health News:Healthy U Chosen as Exclusive Concessions Provider for McHenry's 1st Annual Kicks 4 Kids Youth Charity Soccer Tournament, 2Health News:Healthy U Chosen as Exclusive Concessions Provider for McHenry's 1st Annual Kicks 4 Kids Youth Charity Soccer Tournament, 3Health News:Healthy U Chosen as Exclusive Concessions Provider for McHenry's 1st Annual Kicks 4 Kids Youth Charity Soccer Tournament, 4Health News:PTSD: The serotonin system influences vulnerability and treatment 2Health News:NT-proBNP is a predictor of CV risk in arthritis patients taking NSAIDs 2Health News:Athletes for Hope Awarded $2 Million Grant by Kellogg Foundation 2Health News:Athletes for Hope Awarded $2 Million Grant by Kellogg Foundation 3
    Indications For Usage: ,Bypass upper airway obstructions, provide long term ventilation, support and/or manage tracheal/bronchial secretions...
    Disposable Cannula Cuffless Tracheostomy Tubes...
    Indications For Usage: ,For use with percutaneous tracheotomies...
    Disposable Cannula Cuffed Tracheostomy Tubes...
    Medicine Products: